SIG Brokerage’s Regeneron Pharmaceuticals REGN Stock Holding History

SIG Brokerage’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,064	Closed	-$732K	–	690
2024 Q4	$758K	Buy	+1,064	New	+$893K	0.04%	275

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SIG Brokerage's REGN Position: Q1 2025 in Review

SIG Brokerage sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 1,064 shares — an estimated $732K sold.

SIG Brokerage first reported a position in REGN in Q4 2024 and held it in 1 quarter. The position peaked at $758K in Q4 2024. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

SIG Brokerage reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
SIG Brokerage sold 1,064 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $732K.
SIG Brokerage first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 1 quarter.
SIG Brokerage's Regeneron Pharmaceuticals position peaked at $758K in Q4 2024.
1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on SIG Brokerage's 13F filing for Q1 2025, filed 14 May 2025.